C U Correll

Summary

Affiliation: Long Island Jewish Medical Center
Country: USA

Publications

  1. doi request reprint Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY 11004, USA
    J Am Acad Child Adolesc Psychiatry 47:9-20. 2008
  2. pmc Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome
    Christoph U Correll
    Albert Einstein College of Medicine, Department of Psychiatry, Bronx, NY, USA
    Schizophr Bull 33:703-14. 2007
  3. ncbi request reprint Balancing efficacy and safety in treatment with antipsychotics
    Christoph U Correll
    Recognition and Prevention Program, Zucker Hillside Hospital, Queens, New York, USA
    CNS Spectr 12:12-20, 35. 2007
  4. ncbi request reprint Real-life dosing with second-generation antipsychotics
    Christoph U Correll
    The Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 66:1610-1. 2005
  5. doi request reprint Tardive dyskinesia and new antipsychotics
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Curr Opin Psychiatry 21:151-6. 2008
  6. doi request reprint Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
    Taishiro Kishimoto
    To whom correspondence should be addressed Division of Psychiatry Research, The Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, US tel 718 470 4812, fax 718 343 1659, E mail
    Schizophr Bull 40:192-213. 2014
  7. pmc Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials
    Masahiro Nitta
    To whom correspondence should be addressed Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004 tel 718 470 4812, fax 718 343 1659, E mail
    Schizophr Bull 39:1230-41. 2013
  8. doi request reprint Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes
    Christoph U Correll
    Zucker Hillside Hospital, Hofstra North Shore Long Island Jewish School of Medicine, Glen Oaks, NY 11004, USA
    J Am Acad Child Adolesc Psychiatry 52:689-698.e3. 2013
  9. pmc Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice
    Christoph U Correll
    The Zucker Hillside Hospital, Division of Psychiatry Research, North Shore LIJ Health System, 75 59, 263rd Street, Glen Oaks, NY 11004, USA
    Psychiatr Clin North Am 35:661-81. 2012
  10. pmc Cost of antipsychotic polypharmacy in the treatment of schizophrenia
    Baojin Zhu
    Eli Lilly and Company, Indianapolis, Indiana, USA
    BMC Psychiatry 8:19. 2008

Research Grants

Collaborators

Detail Information

Publications76

  1. doi request reprint Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY 11004, USA
    J Am Acad Child Adolesc Psychiatry 47:9-20. 2008
  2. pmc Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome
    Christoph U Correll
    Albert Einstein College of Medicine, Department of Psychiatry, Bronx, NY, USA
    Schizophr Bull 33:703-14. 2007
    ..The presence and specificity of a bipolar prodrome remains questioned. We aimed to characterize the prodrome prior to a first psychotic and nonpsychotic mania and to examine the phenotypic proximity to the schizophrenia prodrome...
  3. ncbi request reprint Balancing efficacy and safety in treatment with antipsychotics
    Christoph U Correll
    Recognition and Prevention Program, Zucker Hillside Hospital, Queens, New York, USA
    CNS Spectr 12:12-20, 35. 2007
    ....
  4. ncbi request reprint Real-life dosing with second-generation antipsychotics
    Christoph U Correll
    The Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 66:1610-1. 2005
  5. doi request reprint Tardive dyskinesia and new antipsychotics
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Curr Opin Psychiatry 21:151-6. 2008
    ..To provide an update on tardive dyskinesia rates in patients treated with first-generation or second-generation antipsychotics in studies published since the last systematic review in 2004...
  6. doi request reprint Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
    Taishiro Kishimoto
    To whom correspondence should be addressed Division of Psychiatry Research, The Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, US tel 718 470 4812, fax 718 343 1659, E mail
    Schizophr Bull 40:192-213. 2014
    ..Because this finding is vulnerable to a cohort bias, studies comparing FGA-LAI vs second-generation antipsychotics-LAI and LAI vs OAP RCTs in real-world patients are needed. ..
  7. pmc Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials
    Masahiro Nitta
    To whom correspondence should be addressed Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004 tel 718 470 4812, fax 718 343 1659, E mail
    Schizophr Bull 39:1230-41. 2013
    ..To meta-analytically assess the efficacy and tolerability of nonsteroidal anti-inflammatory drugs (NSAIDs) vs placebo in schizophrenia...
  8. doi request reprint Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes
    Christoph U Correll
    Zucker Hillside Hospital, Hofstra North Shore Long Island Jewish School of Medicine, Glen Oaks, NY 11004, USA
    J Am Acad Child Adolesc Psychiatry 52:689-698.e3. 2013
    ..The trajectory of antipsychotic response and the predictive value of early antipsychotic effects were investigated for ultimate outcome in adolescent schizophrenia, where such data are still lacking...
  9. pmc Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice
    Christoph U Correll
    The Zucker Hillside Hospital, Division of Psychiatry Research, North Shore LIJ Health System, 75 59, 263rd Street, Glen Oaks, NY 11004, USA
    Psychiatr Clin North Am 35:661-81. 2012
    ....
  10. pmc Cost of antipsychotic polypharmacy in the treatment of schizophrenia
    Baojin Zhu
    Eli Lilly and Company, Indianapolis, Indiana, USA
    BMC Psychiatry 8:19. 2008
    ..This study compared the costs of antipsychotic polypharmacy for patients who initiated on 1 of the 3 most commonly prescribed atypical antipsychotics - olanzapine, quetiapine, or risperidone...
  11. pmc Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
    Douglas Faries
    Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana, USA
    BMC Psychiatry 5:26. 2005
    ..This study assessed the annual rate and duration of antipsychotic monotherapy and its inverse, antipsychotic polypharmacy, among schizophrenia patients initiated on commonly used atypical antipsychotic medications...
  12. doi request reprint Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics
    Christoph U Correll
    Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 72:655-70. 2011
    ....
  13. pmc Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, New York, NY 11004, USA
    Schizophr Bull 35:443-57. 2009
    ..Despite lacking evidence for its safety and efficacy, antipsychotic cotreatment is common in schizophrenia. Objective: To evaluate therapeutic and adverse effects of antipsychotic cotreatment vs monotherapy in schizophrenia...
  14. doi request reprint Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Bipolar Disord 10:788-97. 2008
    ..We compared bipolar disorder and schizophrenia patients receiving SGAs to determine whether MetS prevalence is influenced by the primary psychiatric diagnosis or concomitant mood stabilizer treatment...
  15. doi request reprint Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients
    Christoph U Correll
    Zucker Hillside Hospital, North Shore Long Island Jewish Health System Glen Oaks, New York 11004, USA
    Int Rev Psychiatry 20:195-201. 2008
    ..Research is required to elucidate risk factors, mechanisms and best interventions for antipsychotic related adverse endocrine and metabolic effects in pediatric patients...
  16. ncbi request reprint Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?
    Christoph U Correll
    Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 69:578-83. 2008
    ..The study was performed in patients receiving second-generation antipsychotics (SGAs), a medication class associated with CHD risk...
  17. ncbi request reprint One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    J Child Adolesc Psychopharmacol 17:647-56. 2007
    ..The aim of this study was to assess the 1-year risk of second-generation antipsychotics (SGAs) for tardive dyskinesia (TD) in children and adolescents with assumed minimal past exposure to first-generation antipsychotics...
  18. ncbi request reprint Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents
    Christoph U Correll
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 69:26-36. 2008
    ....
  19. pmc Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    J Child Adolesc Psychopharmacol 18:475-90. 2008
    ....
  20. pmc Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Schizophr Res 131:58-62. 2011
    ..Although common in psychiatric practice, reasons for antipsychotic polypharmacy (APP) have remained unclear...
  21. doi request reprint Understanding schizoaffective disorder: from psychobiology to psychosocial functioning
    Christoph U Correll
    Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 71:8-13. 2010
    ..These data, although inconclusive, contribute to clinicians' understanding of the etiology of the disorder. Further research may lead to an increased understanding of the disorder, improved treatment, and, ultimately, better outcomes...
  22. doi request reprint Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients
    Christoph U Correll
    Psychiatry Research Division, Zucker Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, NY 11004, USA
    Psychiatr Serv 61:892-8. 2010
    ..A national cardiometabolic screening program for patients in a variety of public mental health facilities, group practices, and community behavioral health clinics was funded by Pfizer Inc. between 2005 and 2008...
  23. doi request reprint From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
    C U Correll
    The Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Eur Psychiatry 25:S12-21. 2010
    ..To optimize outcomes, antipsychotic treatment should be pharmacologically informed and measurement based, combining both acute and long-term management goals and balancing efficacy and adverse effect considerations...
  24. pmc Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    Dialogues Clin Neurosci 13:155-72. 2011
    ....
  25. doi request reprint Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Bipolar Disord 12:116-41. 2010
    ..To compare antipsychotic and mood stabilizer (MS) efficacy and tolerability in youth and adults with bipolar mania...
  26. doi request reprint What are we looking for in new antipsychotics?
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd St, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 72:9-13. 2011
    ..It is hoped that research on drug-specific biomarkers that can predict response in specific patient groups will advance personalized psychiatric care and improve patient outcomes...
  27. pmc Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
    Christoph U Correll
    Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, 75 59 263rd St, Glen Oaks, NY 11004, USA
    JAMA 302:1765-73. 2009
    ..Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication...
  28. pmc Research in people with psychosis risk syndrome: a review of the current evidence and future directions
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    J Child Psychol Psychiatry 51:390-431. 2010
    ..While the research conducted to date has already yielded crucial information, the translation of the concept of a clinically identifiable PRS into clinical practice does not seem justified at this point...
  29. ncbi request reprint Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    J Child Adolesc Psychopharmacol 15:418-33. 2005
    ..The aim of this study was to examine the characteristics and outcome of adolescents with psychotic disorder not otherwise specified (PsyNOS) and brief psychotic disorder (BrPsy), two neglected subsyndromal diagnostic entities...
  30. ncbi request reprint Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?
    Christoph U Correll
    The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 66:1331-2. 2005
  31. ncbi request reprint Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Child Adolesc Psychiatr Clin N Am 15:177-206. 2006
    ..This article presents an overview of SGA-related side effects in children and adolescents and strategies to monitor health outcomes effectively in youngsters receiving SGAs...
  32. doi request reprint Individualizing antipsychotic treatment selection in schizophrenia: characteristics of empirically derived patient subgroups
    C U Correll
    The Zucker Hillside Hospital Center for Translational Psychiatry, The Feinstein Institute for Medical Research, Glen Oaks, USA
    Eur Psychiatry 26:3-16. 2011
    ..7%). The presence of these subgroups, which require confirmation and extension regarding potentially identifiable biological markers, may help individualizing treatment in patients with schizophrenia...
  33. ncbi request reprint Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies
    Christoph U Correll
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Schneider Children s Hospital, Glen Oaks, NY 11004, USA
    Am J Psychiatry 161:414-25. 2004
    ..This hypothesis was examined in a systematic review of studies involving open or controlled treatment with any second-generation antipsychotic...
  34. ncbi request reprint Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    J Am Acad Child Adolesc Psychiatry 45:771-91. 2006
    ..Endocrine and metabolic adverse effects are among the most concerning adverse effects of commonly used psychotropic medications...
  35. pmc Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, United States
    Schizophr Res 89:91-100. 2007
    ..To determine whether the coprescribing of two or more antipsychotics, a relatively frequent practice with little data to support its safety and efficacy, is associated with an increased prevalence of metabolic syndrome...
  36. ncbi request reprint Early identification and high-risk strategies for bipolar disorder
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Bipolar Disord 9:324-38. 2007
    ..To describe and compare the relative merits of different identification strategies for individuals at risk for bipolar disorder (BPD)...
  37. ncbi request reprint Early prediction of antipsychotic response in schizophrenia
    Christoph U Correll
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Am J Psychiatry 160:2063-5. 2003
    ..The authors' goal was to examine the predictive value of early symptom changes indicating response to antipsychotic medication in schizophrenia...
  38. ncbi request reprint Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials
    Christoph U Correll
    Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    J Am Acad Child Adolesc Psychiatry 46:687-700. 2007
    ..To review weight and metabolic effects of mood-stabilizing treatments in pediatric bipolar disorder...
  39. ncbi request reprint Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 67:575-83. 2006
    ....
  40. ncbi request reprint Metabolic effects of treatment with atypical antipsychotics
    John M Kane
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA
    J Clin Psychiatry 65:1447-55. 2004
  41. ncbi request reprint Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications
    David Straker
    Department of Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
    Am J Psychiatry 162:1217-21. 2005
    ..The authors' goal was to explore the relationship between second-generation antipsychotics and the metabolic syndrome...
  42. ncbi request reprint Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Cincinnati College of Medicine, 260 Stetson St, Suite 3224, Cincinnati, OH 45267 0559, USA
    J Clin Psychiatry 70:4-46. 2009
    ..Summit faculty member opinion is compared with field survey results, and recommendations are made for future research...
  43. doi request reprint Frequency and correlates of inappropriate pediatric psychiatric emergency room visits
    Erin Callahan Soto
    Columbia University Medical Center, New York, New York, USA
    J Clin Psychiatry 70:1164-77. 2009
    ..Despite increasing pediatric psychiatric emergency room service (PPERS) visits, data are lacking regarding visit characteristics and appropriateness...
  44. doi request reprint Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials
    John M Kane
    The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    J Psychopharmacol 24:1019-29. 2010
    ..In conclusion, akathisia with aripiprazole occurred early in treatment, was mild-to-moderate in severity, led to few study discontinuations, and did not compromise therapeutic efficacy...
  45. doi request reprint A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy
    John M Kane
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004 1150, USA
    J Clin Psychiatry 70:1348-57. 2009
    ..Combining antipsychotics is common practice in the treatment of schizophrenia. This study investigated aripiprazole adjunctive to risperidone or quetiapine for treating schizophrenia and schizoaffective disorder...
  46. doi request reprint Predictors of insulin resistance in the obese with metabolic syndrome
    Peter Manu
    The Zucker Hillside Hospital, 59 75 263rd Street, Glen Oaks, NY 11004, USA
    Eur J Intern Med 21:409-13. 2010
    ..In the obese, the metabolic syndrome (MetS) is assumed to reflect insulin resistance...
  47. pmc Past and present progress in the pharmacologic treatment of schizophrenia
    John M Kane
    Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 71:1115-24. 2010
    ....
  48. ncbi request reprint The assessment of "prodromal schizophrenia": unresolved issues and future directions
    Todd Lencz
    Albert Einstein College of Medicine, Bronx, NY, USA
    Schizophr Bull 29:717-28. 2003
    ..The dimensional quantification of prodromal symptom severity may be an important direction for future studies of the assessment of at-risk states...
  49. ncbi request reprint A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents
    Ema Saito
    Department of Psychiatry Research, The Zucker Hillside Hospital, Long Island Jewish Medical Center, New Hyde Park, NY, USA
    J Child Adolesc Psychopharmacol 14:350-8. 2004
    ..We hypothesized: (1) risperidone would be associated with hyperprolactinemia most frequently, and (2) postpubertal females may be at higher risk of prolactin elevation and associated adverse effects...
  50. ncbi request reprint Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents
    Barbara A Cornblatt
    Recognition and Prevention RAP Program, Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 68:546-57. 2007
    ..This study reports the results of a prospective, naturalistic treatment study of adolescents considered to be in the prodromal (i.e., prepsychotic) phase of schizophrenia...
  51. ncbi request reprint The schizophrenia prodrome revisited: a neurodevelopmental perspective
    Barbara A Cornblatt
    Albert Einstein College of Medicine, Bronx, NY, USA
    Schizophr Bull 29:633-51. 2003
    ..We conclude that a neurodevelopmental model of schizophrenia is supported by our data and that a range of novel treatment strategies may be neuroprotective by directly affecting the disorder's vulnerability core...
  52. ncbi request reprint Treatment models and designs for intervention research during the psychotic prodrome
    John M Kane
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Schizophr Bull 29:747-56. 2003
    ..Finally, the methodology of completed and ongoing intervention trials in putative prodromal populations is discussed...
  53. ncbi request reprint Real-life switching strategies with second-generation antipsychotics
    Christoph U Correll
    The Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 67:160-1. 2006
  54. ncbi request reprint Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia
    Todd Lencz
    Recognition and Prevention Program, Lake Success, NY 11042, USA
    Schizophr Res 68:37-48. 2004
    ....
  55. ncbi request reprint Genomics and the future of pharmacotherapy in psychiatry
    Anil K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Int Rev Psychiatry 19:523-30. 2007
    ..These increasingly comprehensive approaches should provide informative data on the genes associated with psychotropic drug response, a critical step towards the ultimate goal of 'personalized' medicine...
  56. pmc Pharmacologic treatment of schizophrenia
    John M Kane
    Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Dialogues Clin Neurosci 12:345-57. 2010
    ..Moreover, new treatment options are needed that affect nondopaminergic targets with relevance for symptom reduction, relapse prevention, enhanced efficacy for nonresponders, and reduced key adverse effects...
  57. pmc Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics
    T Kishimoto
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Mol Psychiatry 18:53-66. 2013
    ..Regardless, treatment selection needs to be individualized considering patient- and medication-related factors...
  58. ncbi request reprint Pharmacogenetics of antipsychotic-induced weight gain
    Christoph U Correll
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Psychopharmacology (Berl) 174:477-89. 2004
    ..To enhance power, future studies should pay close attention to population selection and avoidance/control of confounds, particularly past treatment exposure...
  59. ncbi request reprint Effect of hyperprolactinemia during development in children and adolescents
    Christoph U Correll
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks
    J Clin Psychiatry 69:e24. 2008
    ..Clinicians may need to employ pharmacotherapeutic interventions such as reducing dosage, switching antipsychotics, or prescribing adjunctive agents to minimize or prevent these negative side effects and improve patients' outcomes...
  60. doi request reprint Symptomatic presentation and initial treatment for schizophrenia in children and adolescents
    Christoph U Correll
    Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, USA
    J Clin Psychiatry 71:e29. 2010
    ..Treatment regimens that include both pharmacotherapy and psychosocial interventions are needed to comprehensively treat children and adolescents with schizophrenia...
  61. ncbi request reprint Antipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?
    Christoph U Correll
    Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
    J Clin Psychiatry 69:674-5. 2008
  62. doi request reprint The QTc interval and its dispersion in patients receiving two atypical antipsychotics
    Christoph U Correll
    Medical Services, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Eur Arch Psychiatry Clin Neurosci 259:23-7. 2009
    ..Polytherapy with atypical antipsychotics is becoming common, but the effect of this practice on the QTc has not been explored in detail...
  63. ncbi request reprint Antipsychotic polypharmacy, Part 2: Why use 2 antipsychotics when 1 is not good enough?
    Christoph U Correll
    Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
    J Clin Psychiatry 69:860-1. 2008
  64. pmc Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality
    Julie B Penzner
    NewYork Presbyterian Hospital Weill Cornell Medical College, New York, New York, USA
    J Child Adolesc Psychopharmacol 19:563-73. 2009
    ..Although stimulants have opposing dopamine receptor and adverse effects, it is unclear whether stimulant co-treatment counteracts the therapeutic or side effects of antipsychotics...
  65. ncbi request reprint Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
    Schizophr Res 92:103-7. 2007
    ..Lowering low-density lipoprotein-cholesterol (LDL-C) to individualized targets of 100, 130 or 160 mg/dl reduces the risk of CHD. We determined the prevalence of above-target LDL-C and its management during psychiatric hospitalization...
  66. pmc Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome
    A M Auther
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Psychol Med 42:2485-97. 2012
    ..Clinical and epidemiological studies suggest an association between cannabis use and psychosis but this relationship remains controversial...
  67. ncbi request reprint Determination of plasma ziprasidone using liquid chromatography with fluorescence detection
    Raymond F Suckow
    Analytical Psychopharmacology Laboratory, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 799:201-8. 2004
    ..The utility of the method is exemplified with the presentation of clinical data from patients receiving ziprasidone...
  68. ncbi request reprint Clinical psychopharmacology of pediatric mood stabilizer and antipsychotic treatment, part 1: challenges and developments
    Christoph U Correll
    The Zucker Hillside Hospital, Glen Oaks
    J Clin Psychiatry 68:1301-2. 2007
  69. pmc Management of antipsychotic-related weight gain
    Lawrence Maayan
    Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA
    Expert Rev Neurother 10:1175-200. 2010
    ..Future research should focus on combining treatment modalities or agents and on exploring novel mechanism-based interventions...
  70. pmc Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis
    Lawrence Maayan
    Child Study Center, New York University School of Medicine, New York, NY, USA
    Neuropsychopharmacology 35:1520-30. 2010
    ..Antipsychotics with no or minimal cardiometabolic liability, as well as interventions that prevent or normalize adverse antipsychotic cardiometabolic effects are needed...
  71. ncbi request reprint Acute and long-term adverse effects of antipsychotics
    Christoph U Correll
    Albert Einstein College of Medicine, Bronx, New York, USA
    CNS Spectr 12:10-4. 2007
  72. ncbi request reprint Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison
    Sanjiv Kumra
    Department of Child and Adolescent Psychiatry, University of Minnesota, Minneapolis, Minnesota 55454 1495, USA
    Biol Psychiatry 63:524-9. 2008
    ..The present study evaluated the effectiveness and safety of clozapine versus "high-dose" olanzapine in treatment-refractory adolescents with schizophrenia...
  73. ncbi request reprint Strategies for dosing and switching antipsychotics for optimal clinical management
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    J Clin Psychiatry 69:4-17. 2008
    ....
  74. ncbi request reprint Paroxetine in the treatment of adolescent major depression
    Christoph U Correll
    J Am Acad Child Adolesc Psychiatry 41:1269; author reply 1270. 2002
  75. ncbi request reprint Pharmacological management of bipolar disorder in a youth with diabetes
    Melissa P DelBello
    University of Cincinnati College of Medicine, USA
    J Am Acad Child Adolesc Psychiatry 46:1375-9. 2007
  76. ncbi request reprint First-episode psychosis: a window of opportunity for best practices
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA, USA
    CNS Spectr 12:1-12; discussion 13-4; quiz 15-6. 2007
    ..The use of first- or second-generation antipsychotics for psychosis treatment, dosing guidelines, and the antipsychotic side-effect profile will also be addressed...

Research Grants3

  1. 3/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)
    Christoph U Correll; Fiscal Year: 2010
    ..The results of this project will inform future treatment for children and adolescents with major psychiatric disorders. The results are also likely to lead to treatments that improve their health and longevity. ..